JENBURKT PHARMACEUTICALS LTD.

JENBURPH

Small Cap | Pharmaceuticals
₹1159.4
+12.34 (+1.07%)

Stock price as on 22 May 2026 at 15:29 PM

Jenburkt pharmaceuticals ltd. share price update

As of the latest trading session, Jenburkt Pharmaceuticals Ltd. share price is currently at ₹1159.4, which is up by ₹12.34 from its previous closing. ...

Jenburkt Pharmaceuticals Ltd. stock performance

Today’s low

₹1,142.35

Today’s high

₹1,174.85

₹1,159.4

52 week low

₹944

52 week high

₹1,410

₹1,159.4
Open
₹1,151.40
Previous close
₹1,147.05
Share volume
701
Total traded value (Lakh)
₹8.11
Upper circuit
₹1,376.45
Lower circuit
₹917.65

Jenburkt Pharmaceuticals Ltd. fundamentals

Market cap (Cr)
₹509.60
P/E ratio (TTM)
14.67
Book value per share
₹446.47
Beta
0.82
Return on equity
20.25%
Earnings per share (TTM)
₹85.23
Dividend yield
1.79%
Net profit/quarter (Cr)
₹10.85

Jenburkt Pharmaceuticals Ltd. technical summary

₹1154.7
+ 0.66 ▲
5
Bearish
11
Bullish
5 Day1,158.7
10 Day1,155.3
12 Day1,151.2
20 Day1,131.8
26 Day1,119.1
50 Day1,089.9
100 Day1,080.5
200 Day1,092.1
5 Day1,160.3
10 Day1,168.2
12 Day1,167.9
20 Day1,125.8
26 Day1,107.3
50 Day1,061.3
100 Day1,061.9
200 Day1,100.5

1147.67

PIVOT

First support
₹0.00
First resistance
₹0.00
Second support
₹0.00
Second resistance
₹0.00
Third support
₹0.00
Third resistance
₹0.00
RSI
59.99
ADX
36.1
MACD
32.09
Williams % R
-48.03
Commodity Channel Index (CCI)
37.23
Date
22 May 2026
Same day
436
Week
824
Month
1,910
1 year
0.83
3 years
0.77
Over 1 month
9.19%
Over 1 year
0.07%
Over 3 months
14.83%
Over 3 years
16.78%
Over 6 months
-3.25%
Over 6 years
18.98%

Investment Returns

Over 1 Month9.19%
Over 3 Months14.83%
Over 6 Months3.25%
Over 1 Year0.07%

Jenburkt Pharmaceuticals Ltd. Shareholding pattern


Public
53.24%
Promoter holdings
46.63%
FII
0%
DII
0.11%
Promoter shares
0%
Promoter sharesShareCategory

Ashish Uttam Bhuta

7,97,607 (18.07%)

Shareholding of Promoter and Promoter Group

Bhuta Holdings Private Limited

6,16,128 (13.96%)

Shareholding of Promoter and Promoter Group

Kalindi Hemendra Bhuta

3,99,700 (9.06%)

Shareholding of Promoter and Promoter Group

Nirmala Vinodkumar Daga

1,45,493 (3.3%)

Public Shareholding

Ranjeet Singh Sibia

66,244 (1.5%)

Public Shareholding

Promoter sharesShareCategory
Ashish Uttam Bhuta7,97,607 (18.07%)Shareholding of Promoter and Promoter Group
Bhuta Holdings Private Limited6,16,128 (13.96%)Shareholding of Promoter and Promoter Group
Kalindi Hemendra Bhuta3,99,700 (9.06%)Shareholding of Promoter and Promoter Group
Nirmala Vinodkumar Daga1,45,493 (3.3%)Public Shareholding
Ranjeet Singh Sibia66,244 (1.5%)Public Shareholding
Bhavika Ashish Bhuta51,637 (1.17%)Shareholding of Promoter and Promoter Group
Kunti Ketan Gala51,278 (1.16%)Shareholding of Promoter and Promoter Group
Rajiv Garg47,413 (1.07%)Public Shareholding
Parshva Kumar Daga46,557 (1.05%)Public Shareholding
Sushila Paraskumar Daga46,346 (1.05%)Public Shareholding
Varun Daga45,450 (1.03%)Public Shareholding
Kaushik Daga45,000 (1.02%)Public Shareholding
Bharath C Jain45,000 (1.02%)Public Shareholding
Asha Mahesh Bhuta37,374 (0.85%)Shareholding of Promoter and Promoter Group
Riddhi Haresh Shroff32,240 (0.73%)Shareholding of Promoter and Promoter Group
Mahesh Harshad Bhuta30,486 (0.69%)Shareholding of Promoter and Promoter Group
Jagruti Ketan Bhuta24,787 (0.56%)Shareholding of Promoter and Promoter Group
Shivani Haresh Shroff17,000 (0.39%)Shareholding of Promoter and Promoter Group

About JENBURKT PHARMACEUTICALS LTD.

Jenburkt Pharmaceuticals Limited, incorporated in 1985, was formed a joint venture to diversify into the healthcare and pharmaceutical industry, by Bhuta family. The Company is engaged in manufacturing and marketing of speciality and high quality pharmaceutical formulations and healthcare products. Presently, the Company manufactures and markets pharmaceutical formulations in India and internationally across 13 countries. It has more than 1,000 stockists and their reach extends to 400,000+ pharmacies across the globe. The organisation caters

Parent Organisation

Indian Private

NSE Symbol

JENBURKT PHARMACEUTICALS LTD.

Founded

1985

JENBURKT PHARMACEUTICALS LTD. CORPORATE ACTION

Dividend dateDividend amountDividend typeRecord dateInstrument type
11 Jul 202518Final11 Jul 2025Equity shares
23 Jul 202415.3Final24 Jul 2024Equity shares
19 Jul 202314.4Final20 Jul 2023Equity shares
21 Jul 202212Final23 Jul 2022Equity shares
30 Aug 202110.2Final01 Sept 2021Equity shares
18 Mar 20208.1Interim19 Mar 2020Equity shares
22 Jul 201910.2Final24 Jul 2019Equity shares
23 Jul 20186Final25 Jul 2018Equity shares
27 Mar 20183Interim28 Mar 2018Equity shares
21 Jul 20178.1Final25 Jul 2017Equity shares
19 Jul 20160.9Final21 Jul 2016Equity shares
17 Mar 20166.3Interim18 Mar 2016Equity shares
31 Aug 20156.3Final02 Sept 2015Equity shares
03 Sept 20145.1Final05 Sept 2014Equity shares
18 Sept 20134.2Final20 Sept 2013Equity shares
23 Jul 20123.5Final25 Jul 2012Equity shares
21 Jul 20113.5Final23 Jul 2011Equity shares
21 Jul 20103Final23 Jul 2010Equity shares
23 Jul 20091.8Final25 Jul 2009Equity shares
23 Jul 20081.25Final25 Jul 2008Equity shares
18 Jul 20071.25Final20 Jul 2007Equity shares
10 Aug 20050Final12 Aug 2005Equity shares

View more stocks

What’s trending

All stocks

LAXMIDENTL

LAXMI DENTAL LIMITED

249.28
+41.54 (+20%)
RCDL

RAJGOR CASTOR DERIVATI L

26.4
+4.4 (+20%)
RAMCOSYS

RAMCO SYSTEMS LTD.

469.5
+78.25 (+20%)
OCCLLTD

OCCL LIMITED

116.01
+19.33 (+19.99%)
View all

Top gainers

TRENT

TRENT LTD

4296.5
+126.10 (+3.02%)
SHRIRAMFIN

SHRIRAM FINANCE LIMITED

941
+26.25 (+2.87%)
AXISBANK

AXIS BANK LIMITED

1285.4
+32.10 (+2.56%)
ICICIBANK

ICICI BANK LTD.

1264.3
+21.50 (+1.73%)
View all

Top losers

MAXHEALTH

MAX HEALTHCARE INS LTD

1023.25
-67.85 (-6.22%)
SUNPHARMA

SUN PHARMACEUTICAL IND L

1844.6
-46.70 (-2.47%)
ITC

ITC LTD

301.7
-6.35 (-2.06%)
ONGC

OIL AND NATURAL GAS CORP.

290
-5.85 (-1.98%)
View all

Frequently asked questions



Related tags


You are here


Related links


Disclaimer

*Disclaimer for Bajaj Finance Limited (‘BFL’):

Stock trading business is carried by Bajaj Financial Securities Limited ("BFSL"), a broker and Depository Participant registered with Securities Exchange Board of India and offers various products/services related to Securities market (Securities market products/services). BFL merely facilitates display of data shared by BFSL on its webpage/mobile application. Such data received from BFSL, or any of its service providers is on “as is” basis. BFL does not make any representation or warranty, express or implied, regarding accuracy, completeness of such data displayed herein.

When you opt to avail the Securities market products/services of BFSL by clicking on the BFSL weblink/mobile app, you will be redirected to BFSL's web page/mobile app for initiation and completion of the transaction. You are supposed to exercise independent diligence by reading all the related documents carefully before deciding to invest in Securities market Products/services.

BFL is a Non-Banking Financial Company carrying the business of acceptance of deposits and providing lending solutions to Retail and Corporate customers. BFL does not offer nor advice on Securities market products/services and shall not be liable or responsible for any of your investment decision."


**Disclaimer: For Bajaj Financial Securities Limited

Investments in the securities market are subject to market risk, read all related documents carefully before investing.

Broking services offered by Bajaj Financial Securities Limited (Bajaj Broking). Reg Office: Bajaj Auto Limited Complex, Mumbai –Pune Road Akurdi Pune 411035. Corporate Office: Bajaj Financial Securities Limited, 1st Floor, Mantri IT Park, Tower B, Unit No 9 & 10, Viman Nagar, Pune, Maharashtra 411014. SEBI Registration No.: INZ000218931 | BSE Cash/F&O/CDS (Member ID:6706) | NSE Cash/F&O/CDS (Member ID: 90177) | DP registration No: IN-DP-418-2019 | CDSL DP No.: 12088600 | NSDL DP No. IN304300 | AMFI Registration No.: ARN –163403.

Details of Compliance Officer: Mr. Boudhayan Ghosh (For Broking/DP/Research) | Email: compliance_sec@bajajbroking.in | Contact No.: 020-4857 4486. For any investor grievances write to compliance_sec@bajajbroking.in/ compliance_dp@bajajbroking.in (DP related)

This content is for educational purpose only. Securities quoted are exemplary and not recommendatory.

Research Services are offered by Bajaj Broking as Research Analyst under SEBI Regn: INH000010043.

For more disclaimer, check here: https://www.bajajbroking.in/disclaimer

Powered by Bajaj Financial Securities Limited (Bajaj Broking)